Evidence map›Paper›PMID 30578470›Full record

ReviewCurrent environmental health reports2018

Pharmacologic and Environmental Endocrine Disruptors in the Pathogenesis of Hypospadias: a Review.

Rajiv Raghavan, Megan E Romano, Margaret R Karagas, Frank J Penna

3 registry-linked trialsOpen access · greenAbstract readReview
In one paragraph

Review in Current environmental health reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05780047 nacompletednot on this mapstarted 2022, after this paper: background citation

Personalized Mobile Intervention to Reduce Exposure to Endocrine Disrupting Chemicals (EDCs) in Women of Child-Bearing Age and Their Partners

TypeinterventionalSponsorMillion Marker Wellness, Inc.Ran2022 to 2022Enrolled434ConditionsEndocrine Disrupting Chemicals, Environmental Exposure, Health Literacy, Bisphenol AArmsMail-in Urine Test for EDCs
NCT06450951 nacompletednot on this mapstarted 2024, after this paper: background citation

A Personalized Digital Intervention Program to Reduce Exposure to Endocrine Disrupting Chemicals Among a Child-Bearing Age Cohort

TypeinterventionalSponsorMillion Marker Wellness, Inc.Ran2024 to 2026Enrolled1,074ConditionsEnvironmental ExposureArmsUrinary EDC metabolite testing, Educational curriculum
NCT07461857 nacompletednot on this mapstarted 2025, after this paper: background citation

Minority-focused Environmental Health Education and Tracking (MEET) Pilot Study

TypeinterventionalSponsorMillion Marker Wellness, Inc.Ran2025 to 2026Enrolled151ConditionsEnvironmental ExposureArmsEducation curriculum
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Endocrine disruptors of sex hormone activities.Molecular and cellular endocrinology · 2022
    Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Rajiv RaghavanDivision of Pediatric Urology, Children's Hospital at Dartmouth, Dartmouth|Geisel School of Medicine, 1 Medical Center Drive, Lebanon, NH, 03756, USA.
Megan E RomanoDepartment of Epidemiology, Dartmouth|Geisel School of Medicine, Lebanon, NH, USA.
Margaret R KaragasDepartment of Epidemiology, Dartmouth|Geisel School of Medicine, Lebanon, NH, USA.
Frank J PennaDivision of Pediatric Urology, Children's Hospital at Dartmouth, Dartmouth|Geisel School of Medicine, 1 Medical Center Drive, Lebanon, NH, 03756, USA. Frank.J.Penna@dartmouth.edu.
Children's Hospital at Dartmouth Hitchcock · USDartmouth College · US

Funding

Project 3: Placental Biomarkers of Exposure and Outcome (Marsit)P01ES022832 · NIEHS · DARTMOUTH COLLEGE · PI MURRAY, CAROLYN J · 2013 to 2018
$4.7M
NIEHS NIH HHS P01 ES022832
6 · The paper itself

Abstract

purpose of reviewEndocrine disrupting chemicals (EDCs) potentially have a role in causing hypospadias malformation through modifiable in-utero exposure. Considering the emerging literature on the role of potential endocrine disrupting substances on the occurrence of hypospadias and the potential to inform public health efforts to prevent the occurrence of these malformations, we have summarized the current literature, identified areas of consensus, and highlighted areas that warrant further investigation. RECENT

findingsPharmaceuticals, such as diethylstilbestrol, progestin fertility treatments, corticosteroids, and valproic acid, have all been associated with hypospadias risk. Data on exposure to dichlorodiphenyltrichloroethane and hexachlorobenzene pesticides, as well as non-persistent pollutants, particularly phthalates, is less consistent but still compelling. Improving exposure assessment, standardizing sample timing to relevant developmental windows, using clear case identification and classification schemes, and elucidating dose-response relationships with EDCs will help to provide clearer evidence. Promising directions for future research include identification of subgroups with genetic hypospadias risk factors, measurement of intermediate outcomes, and study of EDC mixtures that will more accurately represent the total fetal environment.

Indexed as

Endocrine DisruptorsEnvironmental ExposureEnvironmental PollutantsFemaleHexachlorobenzeneHumansHydrocarbons, ChlorinatedHypospadiasInfantMaleOccupational ExposurePesticidesPregnancyPrenatal Exposure Delayed EffectsEndocrine DisruptorsEnvironmental PollutantsHexachlorobenzeneHydrocarbons, ChlorinatedPesticidesEndocrine disrupting chemicalsHypospadiasIn-uteroPesticidesPharmaceuticalsPhthalates

Identifiers

PMID30578470
PMCPMC8502235
OpenAlexW2906668009

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.